Vectus Biosystems (ASX:VBS) Scaled Net Operating Assets

: 0.32 (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vectus Biosystems's operating assets for the quarter that ended in Dec. 2022 was A$2.29 Mil. Vectus Biosystems's operating liabilities for the quarter that ended in Dec. 2022 was A$1.02 Mil. Vectus Biosystems's Total Assets for the quarter that ended in Jun. 2022 was A$3.94 Mil. Therefore, Vectus Biosystems's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2022 was 0.32.

Vectus Biosystems Scaled Net Operating Assets Historical Data

The historical data trend for Vectus Biosystems's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Scaled Net Operating Assets

-1.92

-9.22

-5.90

-0.31

0.20

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Scaled Net Operating Assets										-0.41	-0.11	-0.17	0.32	0.32

Competitive Comparison

For the Biotechnology subindustry, Vectus Biosystems's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Vectus Biosystems Scaled Net Operating Assets Distribution

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Scaled Net Operating Assets falls in comparison to its industry or sector. The grey bar indicates the Scaled Net Operating Assets's extreme value range as defined by GuruFocus.

Vectus Biosystems Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vectus Biosystems's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2022 )
=	(Operating Assets (A: Jun. 2022 )	-	Operating Liabilities (A: Jun. 2022 ))	/	Total Assets (A: Jun. 2021 )
=	(2.655	-	1.454)	/	6.043
=	0.20

where

	Operating Assets		(A: Jun. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.936	-	1.281
=	2.655

	Operating Liabilities		(A: Jun. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7.47	-	0.07	-	5.946
=	1.454

Vectus Biosystems's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2022 )
=	(Operating Assets (Q: Dec. 2022 )	-	Operating Liabilities (Q: Dec. 2022 ))	/	Total Assets (Q: Jun. 2022 )
=	(2.294	-	1.017)	/	3.936
=	0.32

where

	Operating Assets		(Q: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5.85	-	3.556
=	2.294

	Operating Liabilities		(Q: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.017	-	0	-	0
=	1.017

Vectus Biosystems Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

http://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines